Evidence map›Paper›PMID 36920464›Full record

ArticleJMIR diabetes2023

The Clinical Impact of Flash Glucose Monitoring-a Digital Health App and Smartwatch Technology in Patients With Type 2 Diabetes: Scoping Review.

Sergio Diez Alvarez, Antoni Fellas, Derek Santos, Dean Sculley, Katie Wynne, Shamasunder Acharya, Pooshan Navathe, Xavier Girones, Andrea Coda

Open access · goldAbstract readScoping Review
In one paragraph

Article in JMIR diabetes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Sergio Diez AlvarezSchool of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, Australia.ORCID https://orcid.org/0000-0002-3393-5764
Antoni FellasSchool of Health Sciences, College of Health, Medicine and Wellbeing, University of Newcastle, Ourimbah, Australia.ORCID https://orcid.org/0000-0003-1557-6232
Derek SantosSchool of Health Sciences, Queen Margaret University, Edinburgh, United Kingdom.ORCID https://orcid.org/0000-0001-9936-715X
Dean SculleySchool of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, Australia.ORCID https://orcid.org/0000-0003-3972-8309
Katie WynneSchool of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, Australia.ORCID https://orcid.org/0000-0002-7980-3337
Shamasunder AcharyaSchool of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, Australia.ORCID https://orcid.org/0000-0003-4565-1571
Pooshan NavatheCentral Queensland Hospital and Health Service, Brisbane, Australia.ORCID https://orcid.org/0000-0003-1768-355X
Xavier GironesDepartment of Research, Universities de Catalunya, Generalitat de Catalunya, Barcelona, Cataluna, Spain.ORCID https://orcid.org/0000-0002-2329-5927
Andrea CodaSchool of Health Sciences, College of Health, Medicine and Wellbeing, University of Newcastle, Ourimbah, Australia.ORCID https://orcid.org/0000-0003-0427-6672
Hunter Water · AUJohn Hunter Hospital · AUUniversity of Newcastle Australia · AUGeneralitat de Catalunya · ESQueen Margaret University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes has a growing prevalence and confers significant cost burden to the health care system, raising the urgent need for cost-effective and easily accessible solutions. The management of type 2 diabetes requires significant commitment from the patient, caregivers, and the treating team to optimize clinical outcomes and prevent complications. Technology and its implications for the management of type 2 diabetes is a nascent area of research. The impact of some of the more recent technological innovations in this space, such as continuous glucose monitoring, flash glucose monitoring, web-based applications, as well as smartphone- and smart watch-based interactive apps has received limited attention in the research literature.

objectiveThis scoping review aims to explore the literature available on type 2 diabetes, flash glucose monitoring, and digital health technology to improve diabetic clinical outcomes and inform future research in this area.

methodsA scoping review was undertaken by searching Ovid MEDLINE and CINAHL databases. A second search using all identified keywords and index terms was performed on Ovid MEDLINE (January 1966 to July 2021), EMBASE (January 1980 to July 2021), Cochrane Central Register of Controlled Trials (CENTRAL; the Cochrane Library, latest issue), CINAHL (from 1982), IEEE Xplore, ACM Digital Libraries, and Web of Science databases.

resultsThere were very few studies that have explored the use of mobile health and flash glucose monitoring in type 2 diabetes. These studies have explored somewhat disparate and limited areas of research, and there is a distinct lack of methodological rigor in this area of research. The 3 studies that met the inclusion criteria have addressed aspects of the proposed research question.

conclusionsThis scoping review has highlighted the lack of research in this area, raising the opportunity for further research in this area, focusing on the clinical impact and feasibility of the use of multiple technologies, including flash glucose monitoring in the management of patients with type 2 diabetes.

Indexed as

appapplicationdatabasediabetesdiabeticdigitaldigital healtheffectiveflash glucose monitoringglucoseglucose monitoringmanagementmHealthmobile phonemonitoringscoping reviewsmartphonesmartwatchtechnologytype 2 diabeteswearable

Identifiers

PMID36920464
PMCPMC10131890
OpenAlexW4317460730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.